drugset / Trial / NCT00004382

Phase II Study of Tin Mesoporphyrin vs Phototherapy for Hyperbilirubinemia in Premature Newborns

NCT00004382

RandomizedTreatment

Summary

OBJECTIVES: I. Compare the effectiveness of a single dose of tin mesoporphyrin and special blue light phototherapy in controlling hyperbilirubinemia in premature newborns in Greece. II. Evaluate the dose of tin mesoporphyrin sufficient to alleviate the need for phototherapy without adverse effects in these newborns.

Timeline

Start
1999-12
Primary completion
2007-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject stannsoporfin Small molecule

Indications